Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
Holding TWST?
Track your performance easily
TWST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.15 - $60.90
Previous Close$49.18
Volume508.41K
Average Volume (3M)765.78K
Market Cap
$2.92B
Enterprise Value$2.73B
Total Cash (Recent Filing)$276.42M
Total Debt (Recent Filing)$85.03M
Price to Earnings (P/E)―
Beta3.68
Next Earnings
Jan 31, 2025EPS Estimate
-$0.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.60
Shares Outstanding59,356,440
10 Day Avg. Volume1,167,807
30 Day Avg. Volume765,782
Standard Deviation0.21
R-Squared0.20
Alpha0.00824
Financial Highlights & Ratios
Price to Book (P/B)5.17
Price to Sales (P/S)7.84
Price to Cash Flow (P/CF)-40.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.95
Enterprise Value/Gross Profit20.46
Enterprise Value/Ebitda-15.34
Forecast
1Y Price Target
$50.14Price Target Upside1.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Twist Bioscience News
PremiumCompany Announcements
Twist Bioscience Reports Record Revenue in 2024
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSolid FY25 revenue and gross margin guidance builds on FY24 beat and should reassure investors that growth is durable and margins will keep improving.
Growth PotentialThe company's Factory of The Future provides ample capacity to support industry-leading growth for years to come.
Product LaunchesMultiple new product launches and improvements are gaining traction and offer multiple new avenues for upside to current estimates.
Bears Say
Market OutlookThe outlook for the sector is likely to weigh on the shares in the near-medium term until R&D growth across pharma is more clear.
Regulatory EnvironmentThe guide implies significant deceleration, which is viewed as prudent in a changing regulatory environment.
Revenue ConcernsConcerns remain on the long-term trajectory of the synbio market and long-term gross margin profile.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $24.15 and its highest was $60.90 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Currently, no data Available
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Jan 31, 2025 which is in 41 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Nov 18, 2024. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.714 by $0.124.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -$0.64.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 59,356,440 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.714. Following the earnings report the stock price went up 12.307%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Among the largest hedge funds holding Twist Bioscience Corp’s share is ARK Investment Management LLC. It holds Twist Bioscience Corp’s shares valued at 242M.
---
Twist Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.14 (1.95% Upside)
$50.14 (1.95% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.4%
Last 30 Days ▲ 7.9%
Last 30 Days ▲ 7.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
100.65%
12-Months-Change
Fundamentals
Return on Equity
-38.08%
Trailing 12-Months
Asset Growth
-20.88%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q4 2024
0:00 / 0:00
---
TWST Stock 12 Month Forecast
Average Price Target
$50.14
▲(1.95% Upside)
Technical Analysis
Best Analysts Covering TWST
1 Year
1 Year Success Rate
17/28 ratings generated profit
1 Year Average Return
+24.36%
reiterated a buy rating last month
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 60.71% of your transactions generating a profit, with an average return of +24.36% per trade.
---